A MAN who used his car tyres to spray muck on a speed van was fined €500, but not disqualified, at Athy District Court this ...
BOOTS has launched its winter clearance sale in-store with shoppers bagging huge discounts worth up to 70%. The chain is offering cut-price deals on a host of products including health and beauty ...
An Aussie shopper has shared the five items she's loving - including a 'genius' product and a $25 buy that fits perfectly in tiny spaces.
A war of words has erupted over Operation Trolley, with Mayor Tania Tapsell (inset top), Rotorua MP Todd McClay (middle) and Waiariki MP Rawiri Waititi (bottom) among those airing views.
Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Police said that from January 21 to 23, they executed Operation Trolley, which focused on engaging and educating local business managers and enforcing the illegal use or possession of shopping ...
The supermarket chain has rolled out the world's first set of dumbbell shopping baskets and trolley sledges, transforming regular store visits into workout sessions. Based on findings from Iceland ...
After defacing the trolleys, the vandals then spray painted the security cameras, Darryl Ross, president of the museum’s board, said in a statement. The vandals haven’t been caught yet.
After vandals graffitied two historic trolleys earlier this month at the ... "Not only did they damage our artifacts, they spray painted our security cameras. Fortunately, the photos we needed ...
The trolleys that were damaged are the 1914 St. Louis Waterworks ... "Not only did they damage our artifacts, they spray painted our security cameras. Fortunately, the photos we needed were already ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...